MedPath

Ovidrel

Brand Name: Ovidrel

Generic Name: Choriogonadotropin Alfa

Active
Registration Number

BR-916

Dosage Form

Solution for Injection (SC)

Issuance Date

March 31, 2023

Expiry Date

July 23, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mcg/0.5 mL
Packaging0.5 mL Pre-filled pen with 1 needle (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Choriogonadotropin AlfaActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform